Evaluate the Neurological Effects of EryDex on Subjects With A-T
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Dirk Thye, MD
Quince Therapeutics S.p.A.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Copenhagen University Hospital, Rigshospitalet, Department of Pediatric Neurology
Copenhagen, Denmark
- Ikf Pneumologie Gmbh & Co. Kg; Institut Für Klinische Forschung Pneumologie Clinical Research Center Respiratory Diseases
Frankfurt, Germany
- University Hospital Frankfurt, Pediatric and Adolescent Clinic
Frankfurt, Germany
- Spedali Civili Di Brescia, Pediatric Immunology Department
Brescia, Italy
- Policlinico Umberto I, la Sapienza University, Department of Neurosciences and Menthal Health
Roma, Italy
- Oslo University Hospital, Rikshospitalet, Division of Pediatric and Adolescent Medicine, Norwegian National Unit for Newborn Screening
Oslo, Norway
- Medpolonia Sp Zoo
Poznan, Poland
- Instytut "pomnik-Centrum Zdrowia Dziecka", Immunology Clinic
Warsaw, Poland
- Hospital Universitari Vall D'Hebron, Department of Pediatric Neurology
Barcelona, Spain
- Hospital Universitario la Paz, Department of Pediatric Neurology
Madrid, Spain
- University Children'S Hospital Zürich - Eleonore Foundation
Zurich, Switzerland
- University Hospitals Birmingham Nhs Foundation Trust
Birmingham, United Kingdom
- Great Ormond Street Hospital for Children, Zayed Centre for Research
London, United Kingdom
- St George'S University Hospitals Nhs Foundation Trust, Centre for Neonatal and Paediatric Infection
London, United Kingdom
- Nottingham Children'S Hospital, Queen'S Medical Center, Children'S Neurology
Nottingham, United Kingdom
- University of California Los Angeles (ucla), Ataxia Center and Hd Center of Excellence
Los Angeles, California, United States
- the Johns Hopkins Hospital, Division of Pediatric Allergy and Immunology
Baltimore, Maryland, United States
- Cincinnati Children'S Hospital, Division of Neurology
Cincinnati, Ohio, United States
- Ut Health Houston, Department of Pediatrics, Division of Child & Adolescent Neurology
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jun 2024
- Primary completion
- 17 Dec 2025
- Completion
- 17 Dec 2025
- Last update posted
- 30 Apr 2026
- Registered enrollment
- 105
- Registry id
- NCT06193200
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.